QUAGLINO, Pietro
QUAGLINO, Pietro
SCIENZE MEDICHE
"Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors
2022-01-01 Mastorino, Luca; Susca, Sara; Cariti, Caterina; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro
'Aleukemic' granulomatous leukemia cutis.
1998-01-01 TOMASINI C ;QUAGLINO P ;NOVELLI M ;FIERRO MT
'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al
2023-01-01 Mastorino, L; Ortoncelli, M; Dapavo, P; Ribero, S; Quaglino, P
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed?
2012-01-01 Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo
262 Brentuximab vedotin demonstrates superior activity to standard therapy in CD30-expressing (CD30+) cutaneous T-cell lymphoma (CTCL) in the randomized phase 3 ALCANZA study
2017-01-01 Kim, Y.H.; Whittaker, S.; Horwitz, S.M.; Duvic, M.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.; Wolter, P.; Wang, Y.; Palanca-Wessels, M.; Zagadailov, E.; Trepicchio, W.L.; Lin, H.; Little, M.; Prince, H.
593 Inverse psoriasis involvement in moderate to severe psoriatic patients: A comparison between anti IL23 and anti IL17
2023-01-01 Mastorino, L.; Macagno, N.; Dapavo, P.; Ribero, S.; Quaglino, P.
A Case of a Pigmented Epithelioid Melanocytoma on a Mucosal Site
2020-01-01 Ramondetta, Alice; Ribero, Simone; Conti, Luca; Quaglino, Pietro; Broganelli, Paolo
A case of treatment-refractory psoriasis as the first manifestation of an HIV-infection
2023-01-01 Boskovic, Sara; Merli, Martina; Dapavo, Paolo; Siliquini, Niccolò; Borriello, Silvia; Sciamarrelli, Nadia; Aquino, Carola; Mastorino, Luca; Burzi, Lorenza; Drappero, Emanuele; Ferrara, Micol; Ribero, Simone; Quaglino, Pietro
A literature revision in primary cutaneous B-cell lymphoma
2017-01-01 La Selva, R; Alberti Violetti, S.; Delfino, C.; Grandi, V.; Cicchelli, S.; Tomasini CF; Fierro, M.T.; Berti, E.; Pimpinelli, N.; Quaglino, P.
A meta-analysis of melanoma risk in industrial workers
2018-01-01 Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; Fierro, Maria T; Rappersberger, Klemens; Sibilia, Maria; Tosti, Giulio; Ferrucci, Pier F; Caini, Saverio; De Felici, Maria B; Pagliarello, Calogero; Quaglino, Pietro; Sanlorenzo, Martina
A multicenter, d ouble blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study
2019-01-01 Stadler, R.; Scarisbrick, J.; Knobler, R.; Quaglino, P.; Borgmann, M.; Orlovius, M.; Reimann, P.; Danhauser-Riedl, S.
A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients.
2011-01-01 Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli
A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs.
2017-01-01 Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E., Marreaud S, Morris S, Dalle S, Servitje O, Cowan R, Väkevä L, Chaby G, Jonak C., Fox C.P., Ritchie D, Vermeer M.H., Stadler R., Romero P.L.O., Scarisbrick J., Quaglino, P.
A project by the SIDeMaST Immunopathology Group on cutaneous vasculitis
2015-01-01 Papini, M; Quaglino, P.; La Placa, M.; Marzano, A.V.
A retrospective analysis of dabrafenib and/or dabrafenib plus trametinib combination in patients with metastatic melanoma to characterize patients with long-term benefit in the individual patient program (Describe iii)
2021-01-01 Atkinson V.G.; Quaglino P.; Aglietta M.; Del Vecchio M.; Depenni R.; Consoli F.; Bafaloukos D.; Ferrucci P.F.; Tulyte S.; Krajsova I.; Ascierto P.A.; Gueli R.; Arance A.; Gogas H.; Banerjee H.; Saliba T.; de Jong E.; Neyns B.
A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors
2023-01-01 Medri, Matelda; Savoia, Francesco; Foca, Flavia; Miserocchi, Anna; Quaglino, Pietro; Rubatto, Marco; Gullo, Giulia; Nardini, Chiara; Panasiti, Vincenzo; DE Tursi, Michele; DI Marino, Pietro; Brancaccio, Gabriella; Giunta, Emilio F; Napolitano, Stefania; Cinotti, Elisa; Brusasco, Marco; Stanganelli, Ignazio
A simple scoring system for the diagnosis of palmo-plantar pigmented skin lesions by digital dermoscopy analysis.
2012-01-01 Rubegni P; Cevenini G; Nami N; Argenziano G; Saida T; Burroni M; Quaglino P; Bono R; Hofmann-Wellenhof R; Fimiani M.
A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides.
2014-01-01 Ferrara G; Pancione M; Votino C; Quaglino P; Tomasini C; Santucci M; Pimpinelli N; Cusano F; Sabatino L; Colantuoni V.
A traveller's wart: tungiasis
2018-01-01 Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies
2017-01-01 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Superresponders" at biologic treatment for psoriasis: A comparative study among IL17 and IL23 inhibitors | 2022 | Mastorino, Luca; Susca, Sara; Cariti, Caterina; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Ribero, Simone; Quaglino, Pietro | |
| 'Aleukemic' granulomatous leukemia cutis. | 1998 | TOMASINI C ;QUAGLINO P ;NOVELLI M ;FIERRO MT | |
| 'Efficacy of anti-IL-23 and anti-IL-17 after adalimumab failure in psoriatic patients'-response to Yu et al | 2023 | Mastorino, L; Ortoncelli, M; Dapavo, P; Ribero, S; Quaglino, P | |
| 1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? | 2012 | Simone Ribero; Pietro Quaglino; Martina Sanlorenzo; Simona Osella-Abate; Federica Marenco; Tiziana Nardò; Giuseppe Macripò; Maria Teresa Fierro; Maria Grazia Bernengo | |
| 262 Brentuximab vedotin demonstrates superior activity to standard therapy in CD30-expressing (CD30+) cutaneous T-cell lymphoma (CTCL) in the randomized phase 3 ALCANZA study | 2017 | Kim, Y.H.; Whittaker, S.; Horwitz, S.M.; Duvic, M.; Dummer, R.; Scarisbrick, J.; Quaglino, P.; Zinzani, P.; Wolter, P.; Wang, Y.; Palanca-Wessels, M.; Zagadailov, E.; Trepicchio, W.L.; Lin, H.; Little, M.; Prince, H. | |
| 593 Inverse psoriasis involvement in moderate to severe psoriatic patients: A comparison between anti IL23 and anti IL17 | 2023 | Mastorino, L.; Macagno, N.; Dapavo, P.; Ribero, S.; Quaglino, P. | |
| A Case of a Pigmented Epithelioid Melanocytoma on a Mucosal Site | 2020 | Ramondetta, Alice; Ribero, Simone; Conti, Luca; Quaglino, Pietro; Broganelli, Paolo | |
| A case of treatment-refractory psoriasis as the first manifestation of an HIV-infection | 2023 | Boskovic, Sara; Merli, Martina; Dapavo, Paolo; Siliquini, Niccolò; Borriello, Silvia; Sciamarrelli, Nadia; Aquino, Carola; Mastorino, Luca; Burzi, Lorenza; Drappero, Emanuele; Ferrara, Micol; Ribero, Simone; Quaglino, Pietro | |
| A literature revision in primary cutaneous B-cell lymphoma | 2017 | La Selva, R; Alberti Violetti, S.; Delfino, C.; Grandi, V.; Cicchelli, S.; Tomasini CF; Fierro, M.T.; Berti, E.; Pimpinelli, N.; Quaglino, P. | |
| A meta-analysis of melanoma risk in industrial workers | 2018 | Vujic, Igor; Gandini, Sara; Stanganelli, Ignazio; Fierro, Maria T; Rappersberger, Klemens; Sibilia, Maria; Tosti, Giulio; Ferrucci, Pier F; Caini, Saverio; De Felici, Maria B; Pagliarello, Calogero; Quaglino, Pietro; Sanlorenzo, Martina | |
| A multicenter, d ouble blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB–IVB) mycosis fungoides (MF) or Sézary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study | 2019 | Stadler, R.; Scarisbrick, J.; Knobler, R.; Quaglino, P.; Borgmann, M.; Orlovius, M.; Reimann, P.; Danhauser-Riedl, S. | |
| A new T helper subset producing Interleukin 22 increases in multiplesclerosis patients. | 2011 | Simona Rolla; Valentina Bardina; Marinella Clerico; Paola Bonaventura; Pietro Quaglino; Giulia Contessa; Luca Durelli; Francesco Novelli | |
| A phase III study of lenalidomide maintenance after debulking therapy in patients with advanced cutaneous T-cell lymphoma - EORTC 21081 (NCT01098656): results and lessons learned for future trial designs. | 2017 | Bagot M, Hasan B, Whittaker S, Beylot-Barry M, Knobler R, Shah E., Marreaud S, Morris S, Dalle S, Servitje O, Cowan R, Väkevä L, Chaby G, Jonak C., Fox C.P., Ritchie D, Vermeer M.H., Stadler R., Romero P.L.O., Scarisbrick J., Quaglino, P. | |
| A project by the SIDeMaST Immunopathology Group on cutaneous vasculitis | 2015 | Papini, M; Quaglino, P.; La Placa, M.; Marzano, A.V. | |
| A retrospective analysis of dabrafenib and/or dabrafenib plus trametinib combination in patients with metastatic melanoma to characterize patients with long-term benefit in the individual patient program (Describe iii) | 2021 | Atkinson V.G.; Quaglino P.; Aglietta M.; Del Vecchio M.; Depenni R.; Consoli F.; Bafaloukos D.; Ferrucci P.F.; Tulyte S.; Krajsova I.; Ascierto P.A.; Gueli R.; Arance A.; Gogas H.; Banerjee H.; Saliba T.; de Jong E.; Neyns B. | |
| A retrospective observational study on cutaneous adverse events induced by immune checkpoint inhibitors | 2023 | Medri, Matelda; Savoia, Francesco; Foca, Flavia; Miserocchi, Anna; Quaglino, Pietro; Rubatto, Marco; Gullo, Giulia; Nardini, Chiara; Panasiti, Vincenzo; DE Tursi, Michele; DI Marino, Pietro; Brancaccio, Gabriella; Giunta, Emilio F; Napolitano, Stefania; Cinotti, Elisa; Brusasco, Marco; Stanganelli, Ignazio | |
| A simple scoring system for the diagnosis of palmo-plantar pigmented skin lesions by digital dermoscopy analysis. | 2012 | Rubegni P; Cevenini G; Nami N; Argenziano G; Saida T; Burroni M; Quaglino P; Bono R; Hofmann-Wellenhof R; Fimiani M. | |
| A specific DNA methylation profile correlates with a high risk of disease progression in stage I classical (Alibert-Bazin type) mycosis fungoides. | 2014 | Ferrara G; Pancione M; Votino C; Quaglino P; Tomasini C; Santucci M; Pimpinelli N; Cusano F; Sabatino L; Colantuoni V. | |
| A traveller's wart: tungiasis | 2018 | Fava, Paolo; Astrua, Chiara; Brizio, Matteo; Cavaliere, Giovanni; Senetta, Rebecca; Fierro, Maria Teresa; Quaglino, Pietro | |
| Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies | 2017 | Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario |